Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Oct-24 10:00 PM View:  | Boyer David W. Chief Corp. Affairs Officer | Neurocrine Biosciences Inc. (NBIX) | 03-Oct-24 | Private Sale (Planned) | 1,295 | $113.66 | $147,190.00 | (77%) 1.67K to 0.38K | |
| 15-Aug-24 5:06 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Sale (Planned) | 4,100 | $150.10 | $615,419.00 | (62%) 6.61K to 2.51K | |
| 15-Aug-24 5:12 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Option Exercise | 14,100 | $73.60 | $1,037,760.00 | 45% 31.53K to 45.63K | 4% |
| 15-Aug-24 5:21 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Option Exercise | 11,570 | $42.76 | $494,733.00 | 10% 119.05K to 130.62K | |
| 15-Aug-24 5:12 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Planned Private Option Sale | 14,100 | $150.38 | $2,120,350.00 | (31%) 45.63K to 31.53K | |
| 15-Aug-24 5:21 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Planned Option Sale | 11,570 | $150.43 | $1,740,450.00 | (9%) 130.62K to 119.05K | |
| 15-Aug-24 5:06 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Option Exercise | 3,043 | $103.52 | $315,011.00 | 46% 6.61K to 9.65K | |
| 15-Aug-24 5:06 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 13-Aug-24 | Planned Option Sale | 3,043 | $150.10 | $456,761.00 | (32%) 9.65K to 6.61K | |
| 08-Aug-24 5:16 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 06-Aug-24 | Option Exercise | 273 | $79.02 | $21,572.50 | 4% 6.61K to 6.88K | (3%) |
| 08-Aug-24 5:16 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 06-Aug-24 | Planned Private Option Sale | 273 | $147.70 | $40,322.10 | (4%) 6.88K to 6.61K | |
| 05-Aug-24 5:18 PM View: | Lippoldt Darin Chief Legal Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Aug-24 | Option Exercise | 2,996 | $79.02 | $236,744.00 | 8% 39.74K to 42.74K | (3%) |
| 05-Aug-24 5:40 PM View: | Cooke Julie Chief Human Resources Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Aug-24 | Option Exercise | 12,632 | $61.82 | $780,910.00 | 69% 18.2K to 30.83K | |
| 05-Aug-24 5:40 PM View: | Cooke Julie Chief Human Resources Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Aug-24 | Planned Option Sale | 12,632 | $153.26 | $1,936,020.00 | (41%) 30.83K to 18.2K | |
| 05-Aug-24 5:18 PM View: | Lippoldt Darin Chief Legal Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Aug-24 | Planned Private Option Sale | 2,996 | $154.01 | $461,423.00 | (7%) 42.74K to 39.74K | |
| 18-Jul-24 4:45 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Option Exercise | 900 | $73.60 | $66,240.00 | 3% 31.53K to 32.43K | 4% |
| 18-Jul-24 5:00 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Option Exercise | 1,957 | $103.52 | $202,589.00 | 26% 7.51K to 9.46K | |
| 18-Jul-24 5:00 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Sale (Planned) | 900 | $150.03 | $135,024.00 | (12%) 7.51K to 6.61K | |
| 18-Jul-24 4:41 PM View: | Lippoldt Darin Chief Legal Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Planned Private Option Sale | 7,004 | $150.00 | $1,050,590.00 | (15%) 46.74K to 39.74K | |
| 18-Jul-24 4:54 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Option Exercise | 930 | $42.76 | $39,766.80 | < 1% 119.05K to 119.98K | |
| 18-Jul-24 4:45 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Planned Private Option Sale | 900 | $150.04 | $135,037.00 | (3%) 32.43K to 31.53K | |
| 18-Jul-24 4:54 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Planned Option Sale | 930 | $150.03 | $139,530.00 | (< 1%) 119.98K to 119.05K | |
| 18-Jul-24 4:41 PM View: | Lippoldt Darin Chief Legal Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Option Exercise | 7,004 | $79.02 | $553,456.00 | 18% 39.74K to 46.74K | (3%) |
| 18-Jul-24 5:12 PM View: | Cooke Julie Chief Human Resources Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Option Exercise | 900 | $61.82 | $55,638.00 | 5% 18.2K to 19.1K | |
| 18-Jul-24 5:12 PM View: | Cooke Julie Chief Human Resources Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Planned Option Sale | 900 | $150.04 | $135,036.00 | (5%) 19.1K to 18.2K | |
| 18-Jul-24 5:00 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 16-Jul-24 | Planned Option Sale | 1,957 | $150.03 | $293,603.00 | (21%) 9.46K to 7.51K | |
| 02-Jul-24 9:36 PM View: | Cooke Julie Chief Human Resources Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Jul-24 | Option Exercise | 10,000 | $61.82 | $618,200.00 | 55% 18.2K to 28.2K | |
| 02-Jul-24 9:36 PM View: | Cooke Julie Chief Human Resources Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Jul-24 | Planned Option Sale | 10,000 | $140.19 | $1,401,860.00 | (35%) 28.2K to 18.2K | |
| 02-Jul-24 9:09 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Jul-24 | Planned Private Option Sale | 272 | $138.11 | $37,565.90 | (3%) 7.78K to 7.51K | |
| 02-Jul-24 9:09 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 01-Jul-24 | Option Exercise | 272 | $79.02 | $21,493.40 | 4% 7.51K to 7.78K | (3%) |
| 04-Jun-24 4:23 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 31-May-24 | Planned Private Option Sale | 273 | $136.55 | $37,278.20 | (4%) 7.78K to 7.51K | |
| 04-Jun-24 4:23 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 31-May-24 | Option Exercise | 273 | $79.02 | $21,572.50 | 4% 7.51K to 7.78K | (3%) |
| 30-May-24 4:38 PM View: | Sherwin Stephen A Director | Neurocrine Biosciences Inc. (NBIX) | 29-May-24 | Planned Option Sale | 40,000 | $133.46 | $5,338,560.00 | (60%) 66.5K to 26.5K | |
| 30-May-24 4:38 PM View: | Sherwin Stephen A Director | Neurocrine Biosciences Inc. (NBIX) | 29-May-24 | Option Exercise | 40,000 | $44.68 | $1,787,350.00 | 151% 26.5K to 66.5K | |
| 21-May-24 5:15 PM View: | Morrow George J Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 4,199 | -- | -- | 100% 0 to 4.2K | |
| 21-May-24 4:57 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 2,100 | -- | -- | 2% 116.95K to 119.05K | |
| 21-May-24 5:27 PM View: | Pops Richard F Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 4,199 | -- | -- | 14% 29.51K to 33.71K | |
| 21-May-24 5:06 PM View: | Norwalk Leslie V Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 2,100 | -- | -- | 100% 0 to 2.1K | |
| 21-May-24 5:35 PM View: | Sharp Shalini Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Planned Option Sale | 1,106 | $141.90 | $156,943.00 | (53%) 2.1K to 0.99K | |
| 21-May-24 4:51 PM View: | Sherwin Stephen A Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 4,199 | -- | -- | 19% 22.3K to 26.5K | |
| 21-May-24 5:27 PM View: | Pops Richard F Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Planned Option Sale | 2,100 | $141.84 | $297,860.00 | (6%) 33.71K to 31.61K | |
| 21-May-24 5:06 PM View: | Norwalk Leslie V Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Planned Option Sale | 1,106 | $141.82 | $156,850.00 | (53%) 2.1K to 0.99K | |
| 21-May-24 4:46 PM View: | Mercier Johanna Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 2,100 | -- | -- | 100% 0 to 2.1K | |
| 21-May-24 5:35 PM View: | Sharp Shalini Director | Neurocrine Biosciences Inc. (NBIX) | 17-May-24 | Option Exercise | 2,100 | -- | -- | 100% 0 to 2.1K | |
| 16-May-24 4:40 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 15-May-24 | Planned Option Sale | 15,000 | $140.24 | $2,103,610.00 | (32%) 46.53K to 31.53K | |
| 16-May-24 4:40 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 15-May-24 | Option Exercise | 15,000 | $73.60 | $1,104,000.00 | 48% 31.53K to 46.53K | |
| 16-May-24 4:55 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 14-May-24 | Planned Option Sale | 12,500 | $135.63 | $1,695,370.00 | (5%) 258.89K to 246.39K | |
| 16-May-24 4:40 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 14-May-24 | Option Exercise | 15,000 | $73.60 | $1,104,000.00 | 48% 31.53K to 46.53K | 4% |
| 16-May-24 4:55 PM View: | Lyons Gary A Director | Neurocrine Biosciences Inc. (NBIX) | 14-May-24 | Option Exercise | 12,500 | $42.76 | $534,500.00 | 5% 246.39K to 258.89K | |
| 16-May-24 4:40 PM View: | Abernethy Matt Chief Financial Officer | Neurocrine Biosciences Inc. (NBIX) | 14-May-24 | Planned Private Option Sale | 15,000 | $135.65 | $2,034,830.00 | (32%) 46.53K to 31.53K | |
| 08-May-24 4:26 PM View: | Delaet Ingrid Chief Regulatory Officer | Neurocrine Biosciences Inc. (NBIX) | 06-May-24 | Planned Private Option Sale | 273 | $140.55 | $38,370.20 | (4%) 7.78K to 7.51K |
